Literature DB >> 3289568

Melanoma antigens: immunological and biological characterization and clinical significance.

M Herlyn1, H Koprowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289568     DOI: 10.1146/annurev.iy.06.040188.001435

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


× No keyword cloud information.
  20 in total

1.  Changes in protein expression during melanoma differentiation determined by computer analysis of 2-D gels.

Authors:  D Easty; I R Hart; K Patel; C Seymour; M Yacoub; A Domscheit; S Gunther; W Postel; A Gorg; M J Dunn
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

2.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

Review 3.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

4.  Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor.

Authors:  D Talarico; M Ittmann; A Balsari; P Delli-Bovi; R S Basch; C Basilico
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 5.  Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.

Authors:  C H Ford; V J Richardson; V S Reddy
Journal:  Indian J Pediatr       Date:  1990 Jan-Feb       Impact factor: 1.967

Review 6.  Idiotypic antibody immunotherapy of cancer.

Authors:  M B Chatterjee; K A Foon; H Köhler
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

7.  Murine monoclonal anti-idiotope antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglycan antigen in cynomolgus monkeys.

Authors:  P Chattopadhyay; J Starkey; W J Morrow; S Raychaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 8.  Immunotherapy with monoclonal antibodies in metastatic melanoma.

Authors:  T A Steffens; D F Bajorin; A N Houghton
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

9.  Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.

Authors:  A Mittelman; Z J Chen; T Kageshita; H Yang; M Yamada; P Baskind; N Goldberg; C Puccio; T Ahmed; Z Arlin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

10.  Expression of different immunological markers by cultured human melanocytes.

Authors:  N Smit; I Le Poole; R van den Wijngaard; A Tigges; W Westerhof; P Das
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.